Hébert Guillaume, Minvielle Etienne, Di Palma Mario, Lemare François
Gustave-Roussy, département de pharmacie clinique, 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France; École de Hautes Études en Santé Publique (EHESP), équipe d'Accueil « Management des Organisations de Santé », 15, avenue du professeur Léon-Bernard, 35043 Rennes cedex, France.
École de Hautes Études en Santé Publique (EHESP), équipe d'Accueil « Management des Organisations de Santé », 15, avenue du professeur Léon-Bernard, 35043 Rennes cedex, France; Gustave-Roussy, Mission « Parcours de soins », 114, rue Édouard-Vaillant, 94805 Villejuif cedex, France.
Bull Cancer. 2018 Mar;105(3):245-255. doi: 10.1016/j.bulcan.2017.11.017. Epub 2018 Feb 25.
Analyze the relationship and expectations of cancer patients towards the community pharmacist in a pharmaceutical care coordination project.
In November 2014, a questionnaire was distributed to ambulatory patients of a university hospital specialized in oncology. Thirteen questions explored the consumption habits and the usage of the pharmacy (typology of consumers, use of goods and benefits consumed), and collected their expectations for pharmaceutical benefits in the context of the management of their cancer.
One thousand two hundred and seventy two patients were included for a final response rate of 78%. Characteristics of the respondents: 64% were women, 63% lived in Île-de-France and 49% took cancer-related treatments (anticancer drugs, supportive care medications). More than 84% of respondents went to pharmacies at least once a month and 95% reported resorting to a single pharmacy. 36% to be ready to share their hospital discharge report with their pharmacist and 61% to have their hospitalization order sent to their "referral" pharmacy to anticipate treatments. Discussion Community pharmacists were perceived positively by the respondents. Patients were willing to share information and be accompanied by this health professional in their cancer care. Their expectations were first and foremost the management of drug-related iatrogenic effects with a report of adverse effects to the hospital, and validated solutions for their management.
在药物治疗协调项目中分析癌症患者与社区药剂师之间的关系及期望。
2014年11月,向一家肿瘤专科医院的门诊患者发放问卷。13个问题探讨了消费习惯和药房使用情况(消费者类型、商品使用及消费益处),并收集了他们在癌症治疗过程中对药物治疗益处的期望。
共纳入1272名患者,最终回复率为78%。受访者特征:64%为女性,63%居住在法兰西岛,49%接受癌症相关治疗(抗癌药物、支持性护理药物)。超过84%的受访者每月至少去一次药房,95%的受访者表示只去一家药房。36%的受访者愿意与药剂师分享出院报告,61%的受访者希望将住院医嘱发送到他们的“指定”药房以提前准备治疗。讨论:受访者对社区药剂师评价积极。患者愿意在癌症护理中与这位医疗专业人员分享信息并接受其陪伴。他们的期望首先是处理药物相关的医源性效应,并向医院报告不良反应,以及针对这些问题的有效解决方案。